Suk-Young Yoo - Concepedia

Author

Suk-Young Yoo

The University of Texas MD Anderson Cancer Center

Also Known As

Suk-Young Yoo

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Regeneron (United States)The University of Melbourne Rice University Children's Cancer Center

About

Suk-Young Yoo is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	452
2	Cell Biology	2	2	57
3	Health Sciences	1	1	101
4	Natural Sciences	1	1	27
5	Biochemistry	1	1	27

Suk-Young Yoo

Publications

Citations

H-Index

Page 1

	Year	Citations
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial Alexander Stratigos, Aleksandar Sekulić, Ketty Peris, The Lancet Oncology MedicineHedgehog Inhibitor TherapyDermatologyCancer TreatmentOncology	2021	266
Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice Kwang Hwa Jung, Wonbeak Yoo, Heather L. Stevenson, Clinical Cancer Research	2017	121
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis Danny Rischin, Nikhil I. Khushalani, Chrysalyne D. Schmults, Journal for ImmunoTherapy of Cancer Cancer ManagementMedian TimeDermatologyOncologyObjective Response Rate	2021	101
Transcriptomic Architecture of the Adjacent Airway Field Cancerization in Non–Small Cell Lung Cancer Humam Kadara, Junya Fujimoto, Suk-Young Yoo, JNCI Journal of the National Cancer Institute	2014	84
KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer Bingbing Dai, Suk-Young Yoo, Geoffrey Bartholomeusz, Cancer Research	2013	77
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer Danny Rischin, Marta Gil-Martín, Antonio González-Martı́n, Gynecologic Oncology	2020	73
Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer John V. Heymach, Terry J. Shackleford, Hai T. Tran, Cancer Prevention Research	2011	53
Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway Yasminka A. Jakubek, Wenhua Lang, Selina Vattathil, Cancer Research	2016	49
Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival Steven M. Kornblau, Peter P. Ruvolo, Ruiyu Wang, Haematologica	2018	40
Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy Bingbing Dai, Shaoyu Yan, Humberto Lara-Guerra, PLoS ONE Mtor ActivationEnhanced Therapeutic EfficacyMedicineFgfr2 Expression LevelBronchial Neoplasm	2015	30

Page 1